Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

John W. Ostrominski, Scott D. Solomon, Brian Claggett et al.|European Journal of Heart Failure|2022

Cited by 32